NOLASCO, SANTI
 Distribuzione geografica
Continente #
NA - Nord America 746
AS - Asia 691
EU - Europa 316
AF - Africa 104
SA - Sud America 97
OC - Oceania 2
Totale 1.956
Nazione #
US - Stati Uniti d'America 717
CN - Cina 330
SG - Singapore 224
IT - Italia 206
KR - Corea 84
BR - Brasile 83
CI - Costa d'Avorio 78
IE - Irlanda 26
IN - India 19
SN - Senegal 19
CA - Canada 18
GB - Regno Unito 17
NL - Olanda 14
FI - Finlandia 11
RU - Federazione Russa 8
JP - Giappone 7
MX - Messico 7
FR - Francia 6
IQ - Iraq 6
PL - Polonia 6
DE - Germania 5
ZA - Sudafrica 5
AT - Austria 4
EC - Ecuador 4
ES - Italia 4
HK - Hong Kong 4
VE - Venezuela 4
AR - Argentina 3
BD - Bangladesh 3
IL - Israele 3
LT - Lituania 3
VN - Vietnam 3
AU - Australia 2
CH - Svizzera 2
DK - Danimarca 2
SE - Svezia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
BB - Barbados 1
CO - Colombia 1
CR - Costa Rica 1
GE - Georgia 1
KE - Kenya 1
MA - Marocco 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PY - Paraguay 1
TR - Turchia 1
TT - Trinidad e Tobago 1
Totale 1.956
Città #
Santa Clara 191
Hefei 190
Dallas 182
Singapore 164
Seoul 84
Abidjan 78
Beijing 42
Chicago 41
Ashburn 39
Civitanova Marche 36
Boardman 32
Los Angeles 31
Dublin 26
Dakar 19
Milan 18
Catania 15
New York 11
Rome 11
Naples 9
Lappeenranta 7
Palermo 7
São Paulo 7
Toronto 7
Biancavilla 6
Bologna 6
Brooklyn 6
Kochi 6
Montreal 6
Amiens 5
Amsterdam 5
Council Bluffs 5
Johannesburg 5
Orem 5
Pune 5
Seattle 5
Warsaw 5
Charlotte 4
Chennai 4
Messina 4
Munich 4
Phoenix 4
Poplar 4
Salvador 4
Tokyo 4
Treviso 4
Verona 4
Astoria 3
Boydton 3
Denver 3
Giarre 3
Helsinki 3
Ho Chi Minh City 3
Madrid 3
Mascalucia 3
Praia Grande 3
Querétaro 3
Reggio Emilia 3
Abbiategrasso 2
Aci Catena 2
Baghdad 2
Bitonto 2
Botucatu 2
Bruneck 2
Buffalo 2
Cagliari 2
Campinas 2
Corato 2
Corsico 2
Erbil 2
Fortaleza 2
Geneva 2
Genoa 2
Giulianova 2
Graz 2
Hirosaki 2
Hong Kong 2
Houston 2
Laives 2
Legnano 2
London 2
Manchester 2
Mexico City 2
Ourinhos 2
Rimini 2
Rio de Janeiro 2
Sant'Anastasia 2
Silkeborg 2
Sorocaba 2
Stockholm 2
Sydney 2
São Bernardo do Campo 2
Tai Wan 2
Taoyuan District 2
Turin 2
Amherstburg 1
Angra dos Reis 1
Ankara 1
Aparecida de Goiânia 1
Aracaju 1
Aracati 1
Totale 1.470
Nome #
High-Flow Nasal Cannula Oxygen Therapy: Physiological Mechanisms and Clinical Applications in Children 130
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 89
Acute and long-term management of severe bronchiectasis with high flow nasal therapy: A case report 88
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 87
Type 2-High Severe Asthma with and without Bronchiectasis: A Prospective Observational Multicentre Study 79
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial 79
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study 79
Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study 75
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 73
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study 70
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study 65
Personalized Medicine in Asthma: Current Approach and Future Perspectives 63
Depemokimab, the first ultra-long-acting anti-IL-5 monoclonal antibody for severe eosinophilic asthma 63
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super‐Response and Remission With Mepolizumab 62
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 61
Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission 61
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 60
Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy 59
Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression 59
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis 58
Eosinophilic Bronchiectasis: Prevalence, Severity, and Associated Features—A Cohort Study 57
Tezepelumab for asthma 57
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 53
Long-Term High-Flow Nasal Therapy in Patients with Bronchiectasis of Different Severity: A Retrospective Cohort Study 52
Are we overlooking the lung function in the definition of severe asthma remission? 51
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study 51
Impact of Long-Term High-Flow Nasal Therapy on Mucus Plugs in Patients with Bronchiectasis 47
“The Kafka’s Disease” 46
Comparability of asthma control test scores between self and physician-administered test 41
Can humidified high flow reverse mucus plugging? 39
Switching Biological Therapies in Severe Asthma 37
Totale 1.991
Categoria #
all - tutte 7.569
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.569


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202389 0 0 0 0 0 0 25 29 20 4 2 9
2023/2024224 6 29 22 19 6 47 4 21 3 8 44 15
2024/2025820 15 87 53 48 146 114 40 23 24 61 102 107
2025/2026858 154 257 256 152 39 0 0 0 0 0 0 0
Totale 1.991